Subscribe: Market Wire - Pharmaceuticals and Biotech: Drugs
http://img.marketwire.com/rss/mwPBDR.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announced  announces  cannabis  cfn media  cfn  company  marketwired  media  nasdaq  new  results  today announced  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Pharmaceuticals and Biotech: Drugs

Marketwired - Drugs



Marketwired - Drugs



Last Build Date: Mon, 29 May 2017 17:29:45 EDT

Copyright: Copyright: (C) Marketwired
 



ABcann Global and Cannabis Wheaton Sign Interim Agreement for Construction of Additional Cannabis Cultivation Facility

Mon, 29 May 2017 16:48:29 EDT

VANCOUVER, BC--(Marketwired - May 29, 2017) - ABcann Global Corporation (TSX VENTURE: ABCN) (formerly Panda Capital Inc.) ("ABcann") and Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) ("Cannabis Wheaton" or "CW") are pleased to report that they have entered into a binding interim agreement (the "Agreement") to fund the construction of 50,000 square feet of cultivation space (the "Expansion Production Area") at ABcann's proposed cannabis cultivation facility to be located in Napanee, Ontario known as the Kimmett facility (the "Facility"). Pursuant to the Agreement, Cannabis Wheaton has agreed to invest $30 million in ABcann as follows:




Trillium Announces Voting Results from the Annual Meeting of Shareholders

Fri, 26 May 2017 16:05:00 EDT

TORONTO, ONTARIO--(Marketwired - May 26, 2017) - Trillium Therapeutics Inc. (NASDAQ:TRIL)(TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced the voting results from its Annual Meeting of shareholders held today. The results of the director elections were as follows:




Tronox to become the largest producer of TiO2 in the world upon the acquisition of Cristal

Fri, 26 May 2017 10:37:21 EDT

Tronox Limited announces a definitive agreement to acquire the Titanium Dioxide production assets of Cristal (The National Titanium Dioxide Company Limited)




Blue Diamond Ventures Inc. announces Strategic Partnership

Fri, 26 May 2017 09:55:37 EDT

Eltron R & D and BLDV join forces to make an ImPAAct(TM) (PAA) in the Cannabis Industry




Amedica Announces Delayed Filing of Quarterly Report on Form 10-Q and Receipt of Nasdaq Letter

Fri, 26 May 2017 09:00:00 EDT

SALT LAKE CITY, UT--(Marketwired - May 26, 2017) - Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, announced today that it has delayed the filing of its Quarterly Report on Form 10-Q for the quarter ended March 31, 2017 ("Form 10-Q").




Emerald Health Launches New Products in Bid to Become Market Leader -- CFN Media

Fri, 26 May 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - May 26, 2017) - CFN Media Group ("CFN Media"), the leading agency and digital media network dedicated to legal cannabis, today announced publication of an article covering Emerald Health Therapeutics Inc.'s (TSX VENTURE: EMH) newly launched cannabidiol (CBD) products and its long-term plan to become a market leader.




Trillium Announces Pricing of US$30.0 Million Public Offering of Common Shares and Series II Non-Voting Convertible First Preference Shares

Fri, 26 May 2017 08:30:00 EDT

TORONTO, ONTARIO--(Marketwired - May 26, 2017) - Trillium Therapeutics Inc. (NASDAQ:TRIL)(TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has priced its previously announced underwritten public offering of 2,750,000 common shares and 3,250,000 Series II Non-Voting Convertible First Preferred Shares. The common shares are being sold at a public offering price of US$5.00 per share and the Series II Non-Voting Convertible First Preferred Shares are being sold at a public offering price of US$5.00 per share. The gross proceeds to the Company from this offering are expected to be approximately US$30.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses. The Company has also granted the underwriters a 30-day option to purchase from it up to an additional 412,500 common shares on the same terms and conditions. The offering is expected to close on June 1, 2017, subject to the satisfaction of customary closing conditions.




Cannabis Science, Inc. Receives U.S. Federal Government Clearance to Receive U.S. Federal Government Contracts

Fri, 26 May 2017 08:16:32 EDT

IRVINE, CA--(Marketwired - May 26, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, has received U.S. Federal Government clearance to receive U.S. Federal Government contracts. As the world's largest customer, the U.S. Federal Government issues over $192 billion in contracts and over $450 billion in grants annually.




The Hydroponics Company Limited Secures Strategic Alliance with US-based pharmaceutical company Phoenix Life Sciences to develop medicinal cannabis internationally

Fri, 26 May 2017 03:30:00 EDT

SINGAPORE--(Marketwired - May 26, 2017) - The Hydroponics Company Limited (ASX: THC) ("THC" or "the Company") is pleased to announce that it has signed an exclusive joint venture agreement with Colorado-based healthcare solutions company Phoenix Life Sciences Inc to cooperatively research, develop, manufacture, distribute and sell medicinal cannabis products in Australia and internationally.




Cannabis Wheaton Bolsters Team, Engages Investor Relations Firm

Fri, 26 May 2017 00:27:44 EDT

VANCOUVER, BC--(Marketwired - May 26, 2017) - Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) ("Cannabis Wheaton", "CW", or the "Company") is pleased to announce that the Company has appointed Sarah Bain Vice-President, External Affairs effective today.




Lion Biotechnologies Announces Departure of Chief Financial Officer

Thu, 25 May 2017 16:45:00 EDT

SAN CARLOS, CA--(Marketwired - May 25, 2017) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that Gregory Schiffman, Chief Financial Officer, has decided to leave the company for personal reasons, preventing him from commuting from his residence in Portland, OR to the Company's corporate headquarters in San Carlos, CA. Mr. Schiffman will remain in his current role until June 22, 2017. A search for a new CFO is underway through a recruitment agency.




Rennova Health Postpones Special Meeting of Stockholders to June 2, 2017

Thu, 25 May 2017 16:15:00 EDT

WEST PALM BEACH, FL--(Marketwired - May 25, 2017) - Rennova Health, Inc. (NASDAQ: RNVA), (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces the postponement of its Special Meeting of stockholders that was to have taken place originally on May 19, 2017, and which was subsequently postponed to May 26, 2017. The second postponement is necessary because a quorum of shares represented at the meeting continues not to be achieved. The new date for the Special Meeting is June 2, 2017 at 11:00 a.m. Eastern time and it will take place at the offices of Shutts & Bowen LLP, 525 Okeechobee Boulevard, Suite 1100, West Palm Beach, FL 33401. The record date of April 21, 2017 remains unchanged.




Trillium Announces Proposed Public Offering

Thu, 25 May 2017 16:01:00 EDT

TORONTO, ONTARIO--(Marketwired - May 25, 2017) - Trillium Therapeutics Inc. (TSX:TRIL)(NASDAQ:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has commenced a public offering of its common shares and Series II Non-Voting Convertible First Preferred Shares. The Series II Non-Voting Convertible First Preferred Shares are being offered to investors whose purchase of common shares in the offering may result in such investor, together with its affiliates and certain related parties, beneficially owning more than 4.99% of the Company's outstanding common shares following the consummation of the offering. The Company also intends to grant the underwriters a 30-day option to purchase from it up to an additional 15% of the common shares offered in the offering.




City of Manchester, New Hampshire Selects Napoli Shkolnik For Opioid Litigation

Thu, 25 May 2017 14:19:17 EDT

NEW YORK, NY--(Marketwired - May 25, 2017) - City alderman from Manchester, New Hampshire voted on Tuesday to authorize the city solicitor to partner with Napoli Shkolnik to represent the city in litigation against pharmaceutical companies that aggressively marketed and distributed prescription opioids. This litigation is being led by Napoli Shkolnik attorneys Paul J. Napoli, Joseph L. Ciaccio and Salvatore C. Badala.




LDS Offers Fully-Integrated Cannabis Opportunity -- CFN Media

Thu, 25 May 2017 09:35:33 EDT

SEATTLE, WA--(Marketwired - May 25, 2017) -  CFN Media Group ("CFN Media"), the leading agency and digital media network dedicated to legal cannabis, today announced publication of an article covering Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF) and its compelling business model in the cannabis industry.




Platinex Leverages Experienced Team to Build Cannabis Destination -- CFN Media

Thu, 25 May 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - May 25, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces publication of an article discussing Platinex Inc.'s (CSE: PTX) experienced team behind the launch of CannabisMall.Shop and CannabisMall.Org. The company will be featuring progressive advances on the two sites continuously prior to launch.




Mexico's Legalization of Medical Marijuana Yields Opportunities -- CFN Media

Thu, 25 May 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - May 25, 2017) -  CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Mexico's pending legalization of medical marijuana, and Medical Marijuana Inc.'s (OTC PINK: MJNA) established position as a leader in the country's nascent industry.




The Life Sciences Report Interviews H.C. Wainwright Analyst Ed Arce

Thu, 25 May 2017 08:45:00 EDT

SAN FRANCISCO, CA--(Marketwired - May 25, 2017) - NASH is an epidemic in the U.S., with more than 100 million people believed to be affected. Yet no FDA-approved treatments are available, with the exception of liver transplantation for end-stage disease. In part two of his interview with The Life Sciences Report, Ed Arce, managing director in equity research and senior analyst covering companies in the biopharmaceuticals and specialty pharmaceuticals sectors for H.C. Wainwright, and organizer of the recent inaugural NASH Investor Conference, says that small companies are rushing to fill the pipeline, with numerous compounds in trials.




The Life Sciences Report Examines Viveve Medical's Record-Breaking Quarter

Thu, 25 May 2017 08:45:00 EDT

SAN FRANCISCO, CA--(Marketwired - May 25, 2017) - Viveve Medical Inc.'s (NASDAQ: VIVE) Q1/17 results beat expectations, an accomplishment that was welcomed by several industry analysts.




Rennova Health Names Michael Pollack Interim Chief Financial Officer

Thu, 25 May 2017 08:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - May 25, 2017) - Rennova Health, Inc. (NASDAQ: RNVA), (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces the appointment of Michael Pollack, CPA as Interim Chief Financial Officer. Mr. Pollack brings approximately 30 years of corporate finance, reporting and consulting experience to Rennova, working with publicly traded and privately held companies with a particular focus on healthcare. Since 2005 Mr. Pollack has been with KBL, LLP, a certified public accounting and business advisory firm, most recently serving as Partner-in-Charge of KBL's audit quality and control, and the Partner-in-Charge of KBL's Public Company (SEC) Practices Group.




UPDATE -- Golden Leaf to Hold Shareholder Call to Review First Quarter 2017 Results

Thu, 25 May 2017 08:00:00 EDT

TORONTO, ON--(Marketwired - May 25, 2017) - Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE: GLH) (CSE: GLH.CN) (CNSX: GLH) (OTCQB: GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced that it will hold a shareholder call to review first quarter 2017 results for the period ended March 31, 2017, at 4:15 pm ET on Tuesday, May 30, 2017.




Pharmaceutical Case Studies Illustrating Data Analytics Strategies: New Webinar Hosted by Xtalks

Thu, 25 May 2017 07:30:00 EDT

Extracting the Most Value from Your Data Assets




HempLife Today Outlines Three to Five Year Plan to Reach $50,000,000 in Annual Sales Revenue

Thu, 25 May 2017 07:00:00 EDT

DENVER, CO--(Marketwired - May 25, 2017) - Ubiquitech Software Corp. (OTC PINK: UBQU), through its subsidiary HempLife TodayT an innovative and growing Company offering the finest CBD (Cannabidiol), products derived from Hemp, is announcing its three to five-year plan to reach $50,000,000 in annual sales revenue. Company gives overview on how it can achieve this goal and the progress it is making toward this stated goal.




Uncover Pharmacovigilance Insights with Data Discovery and Active Surveillance, New Webinar Hosted by Xtalks

Thu, 25 May 2017 07:00:00 EDT

Third in the series Four Steps to Shorten Your Clinical Trials with Informatics




Revive Therapeutics Ltd. Announces Results for the Three and Nine Months Ended March 31, 2017

Thu, 25 May 2017 07:00:00 EDT

TORONTO, ONTARIO--(Marketwired - May 25, 2017) - Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE:RVV) (OTCQB:RVVTF) announced today its results for the three and nine months ended March 31, 2017. The unaudited condensed interim consolidated financial statements and Management's Discussion and Analysis for the period may be viewed on SEDAR at www.sedar.com.




ContraFect Announces Initiation of Phase 2 Study Evaluating CF-301 in Patients with Staphylococcus aureus Bacteremia

Thu, 25 May 2017 07:00:00 EDT

YONKERS, NY--(Marketwired - May 25, 2017) - ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announced the initiation of an international Phase 2 study evaluating its first-in-class lysin, CF-301, as a potential treatment of Staphylococcus aureus (Staph aureus) bacteremia including right sided endocarditis. Staph aureus bacteremia and endocarditis are serious life threatening infections, associated with substantial morbidity and mortality despite currently available conventional antibiotics. This multicenter, randomized, double-blind, placebo-controlled study is designed to evaluate the potential for CF-301 to be used in addition to standard-of-care (SOC) antibiotics to significantly improve clinical success rates compared to SOC antibiotics alone. Safety, tolerability, and pharmacokinetics of CF-301 will also be evaluated in the study. The company expects to announce top line results in Q4 2018.




Global Pharma Teams Likely to Increase Outsourced Patient Adherence Personnel

Wed, 24 May 2017 17:42:00 EDT

Approximately 50% of surveyed global patient adherence teams report increasing outsourced FTEs




Thomas B. King Joins VIVUS' Board of Directors

Wed, 24 May 2017 16:15:00 EDT

CAMPBELL, CA--(Marketwired - May 24, 2017) - VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), announced today that Thomas B. King has been appointed to VIVUS' board of directors. Mr. King's nearly 40 years of pharmaceutical experience ranges from large to development-stage pharmaceutical companies.




UPDATE - CROS NT Announces Extended Partnership With Medidata -- Deploys RaveX

Wed, 24 May 2017 15:42:29 EDT

MAIDENHEAD, UNITED KINGDOM and CHAPEL HILL, NC--(Marketwired - May 24, 2017) - CROS NT today announced the go-live of its RaveX team in an extension of the company's partnership with Medidata.




United Cannabis and Near-Term Cannabinoid Clinical Trials -- CFN Media

Wed, 24 May 2017 14:50:55 EDT

SEATTLE, WA--(Marketwired - May 24, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing United Cannabis Inc.'s (OTCQB: CNAB) progress in initiating clinical trials to study its proprietary Prana Bio Medicinals cannabinoid compounds.




National Lipid Association Releases Results of Survey on Barriers to PCSK9 Inhibitor Prescription Approval Process

Wed, 24 May 2017 14:37:52 EDT

Responses from healthcare workers show significant barriers to prescriptions




KBI Biopharma selects The Windshire Group's and Simplyfeye's ProcessPad(TM) continued process verification solution

Wed, 24 May 2017 12:33:58 EDT

BOSTON, MA--(Marketwired - May 24, 2017) - The Windshire Group, LLC and Simplyfeye Inc. are pleased to announce KBI Biopharma, Inc. will deploy ProcessPadtm for its data analysis, management and reporting solution for process development, product scale-up and commercial manufacturing operations. KBI is a leading CDMO (contract development and manufacturing organization) and has served over 250 clients worldwide, including most of the top ten pharmaceutical companies.




CORRECTION - Cosmos Holdings, Inc. Announces first Quarter 2017 Results

Wed, 24 May 2017 11:40:00 EDT

CHICAGO, IL--(Marketwired - May 24, 2017) - In the news release, "Cosmos Holdings, Inc. Announces first Quarter 2017 Results," issued yesterday, May 23, by Cosmos Holdings (OTCQB: COSM), we are advised by the company that the subhead should read "Revenue Improved 262% and Gross Profit Improved 315% compared to the three months ended March 31, 2016." The "revenue improved" and "gross profit" percentages in the second paragraph were also updated. Complete corrected text follows.




Ovation Receives $1.5M in Funding and Launches Collaboration with iGeneTRAiN

Wed, 24 May 2017 08:57:06 EDT

CAMBRIDGE, MA--(Marketwired - May 24, 2017) -  Ovation Life Sciences, LLC (Ovation) announced today the receipt of 1.5 million dollars in funding from StageDotO, and existing investors, including Longfellow Ventures. The company will use the funds to continue the development of its next-generation scientific data-layer-as-a-service platforms, built to accelerate the progress of life science by improving how the story of scientific data is told. Ovation also announced a partnership with iGeneTRAiN to use Ovation Research to maximize collaboration capabilities across iGeneTRAiN's transplant consortium. The announcement was made today at the 2017 BioIT World Conference and Expo, www.bio-itworldexpo.com.




Rennova Health Reports First Quarter 2017 Financial Results

Wed, 24 May 2017 08:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - May 24, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company") reports financial results for the first quarter ended March 31, 2017 and provides a business update.




How to Upgrade Kombucha and Functional Beverage, Food, Supplement Products with Symbiotic Botanical Fermentation, New Webinar Hosted by Xtalks

Wed, 24 May 2017 08:18:30 EDT

TORONTO, ON--(Marketwired - May 24, 2017) - During a live broadcast, industry expert Chantale Houle, President of Kefiplant, will discuss the upcoming market opportunities for kombucha and botanicals.




The Good, the Bad, the Necessary in Rare Disease Studies, New Webinar Hosted by Xtalks

Wed, 24 May 2017 08:10:14 EDT

Live session on June 8, 2017 features expert panel from INC Research discussing the why, where, when and how a rare disease drug is intended to be used subsequent to approval and the importance of beginning with the end in mind




BioVie Announces Issuance of US Patent Covering BIV201 for the Treatment of Ascites Due to Liver Cirrhosis

Wed, 24 May 2017 08:00:00 EDT

BEVERLY, MA--(Marketwired - May 24, 2017) - BioVie Inc. (OTCQB: BIVI), a clinical-stage company focused on the discovery, development, and commercialization of innovative drug therapies for liver disease, today announced that the US Patent and Trademark Office (USPTO) has issued US Patent No. 9,655,945 covering the Company's new drug candidate BIV201 in development for the treatment of ascites in patients with advanced liver cirrhosis.




Aphria Advances Growth in US Medical Cannabis Market With Completion of Strategic Investment in DFMMJ, and Exclusive Management Agreement With Chestnut Hill Tree Farm LLC

Wed, 24 May 2017 08:00:00 EDT

License transfer to occur after introduction of new Florida regulations

Aphria and DFMMJ plan to significantly increase the size of Chestnut within six months




Harvest One Announces Appointment of Will Stewart to Board of Directors

Wed, 24 May 2017 07:30:00 EDT

TORONTO, ONTARIO--(Marketwired - May 24, 2017) - Harvest One Cannabis Inc. (TSX VENTURE:HVST) ("Harvest One" or the "Company") is pleased to announce that Mr. Will Stewart has joined its board of directors (the "Board"). Mr. Stewart will replace Ms. Anne Chopra on the Board, who has resigned to focus her efforts on other ventures. The Board thanks Ms. Chopra for her contributions to the Company. Prior to his appointment to the Board, Mr. Stewart had served on the advisory board of the Company.




Easton Pharmaceuticals Announces It Has Signed an LOI to Acquire An Interest in a 45 Acre Parcel for the Cultivation of Medical Marijuana in Toronto, Canada; Wholly Owned Subsidiary, iBliss in Birmingham's UK Vaper Expo

Wed, 24 May 2017 07:28:28 EDT

TORONTO, ON--(Marketwired - May 24, 2017) -  Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) is pleased to announce that it has signed a Letter of Intent with Canadian Alliance Group to acquire an interest in their 45 acre fully owned parcel of land for the cultivation, production and sale of medical marijuana to the cannabis industry. Easton's wholly owned subsidiary, iBliss Inc. is currently in Birmingham, UK for this weekend's Vaper expo.




Government Account Manager Staffing Levels Surpass Those of Pharmacy Account Managers in Global Pharma Market Access Teams

Tue, 23 May 2017 18:26:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - May 23, 2017) - Market access teams across Top 10, Top 50 and small pharmaceutical companies are more likely to employ higher numbers of full-time equivalents (FTEs) to support government accounts compared to pharmacy accounts, according to a recently released study by business intelligence provider, Cutting Edge Information.




Tetra Bio-Pharma Signs Definitive Agreement for Two Products with Panag Pharma

Tue, 23 May 2017 16:00:00 EDT

OTTAWA, ONTARIO--(Marketwired - May 23, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF), announced today it has signed a definitive agreement with Panag Pharma Inc. for the development and commercialization of novel cannabinoid based formulations for the treatment of pain and inflammation. Combined total market potential of both products in the USA in 2014 is estimated over US$5.5 billion. The recent press release on May 17th for the filing of a patent in ocular disease combined with the patents from Panag in the ocular space make this agreement very lucrative.




Cannabis Wheaton Announces Revised Offering Size and Expanded Syndicate

Tue, 23 May 2017 14:43:22 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 23, 2017) -




Cosmos Holdings, Inc. Announces first Quarter 2017 Results

Tue, 23 May 2017 12:28:12 EDT

Revenue Improved 362% and Gross Profit Improved 415% compared to the three months ended March 31, 2016




Science Exchange Invited to Speak at the Novartis Institutes for Biomedical Research (NIBR) Seminar

Tue, 23 May 2017 12:00:00 EDT

Elizabeth Iorns, Ph.D., Founder and CEO of Science Exchange will present the Reproducibility Project: Cancer Biology




Marijuana Company of America Announces the Filing of Form 10 Registration Statement with SEC

Tue, 23 May 2017 10:59:31 EDT

BONSALL, CA--(Marketwired - May 23, 2017) - MARIJUANA COMPANY OF AMERICA, INC ("MCOA" or the "Company") (OTC PINK: MCOA), an innovative cannabis and hemp company, is pleased to announce that it has filed a Form 10 Registration Statement with the U.S. Securities and Exchange Commission (SEC). This is an important step in helping the Company to raise the necessary capital to fund its projects and expand its operations, as well as provide more transparent and reliable information to investors.




Amazonas Florestal Ltd. Announced Today That The Company's Wholly Owned Subsidiary Amazon Hemp Has Completed the Planting of Its First 100-Acre CBD Hemp Plantation in the State of Colorado

Tue, 23 May 2017 10:16:10 EDT

MIAMI, FL--(Marketwired - May 23, 2017) -  Amazonas Florestal, Ltd. (www.azflusa.com) (OTC PINK: AZFL), a natural resources company dedicated to innovative, sustainable forest management, Industrial CBD Hemp and the certification and sales of carbon credits, today announced that the company's wholly owned subsidiary Amazon Hemp has completed Planting of its first 100 Acre CBD Hemp Plantation in the State of Colorado. The Company announced today that on May 16th, 2017, company contractors completed the planting of 236,700 High CBD Hemp seeds in the 100-acre field located in Weld County. The Company also announced that it expects to plant its second 100-acre field on or about May 24th, 2017.




Protext Mobility Completes Name Change to Protext Pharma and Provides Update on Medical Cannabis License

Tue, 23 May 2017 10:00:00 EDT

BOCA RATON, FL--(Marketwired - May 23, 2017) - Protext Pharma, Inc. (OTC PINK: TXTM) ("Protext" or "the Company"), a biotech company engaged in the development of pharmaceutical applications with highly bioavailable Phytofare® extracts, has announced today that its name change to Protext Pharma, Inc is now effective with the State of Delaware, and is pleased to provide the following shareholders update on its wholly owned subsidiary Cannabis Biosciences. The Company expects to submit the name change to FINRA in the coming days.




SinglePoint Continues Acquisition Strategy with New LOI -- CFN Media

Tue, 23 May 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - May 23, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article that covers SinglePoint Inc.'s (OTC PINK: SING) recently announced letter of intent with Discount Indoor Garden Supply.




ABcann's Pesticide-Free Approach is a Breath of Fresh Air -- CFN Media

Tue, 23 May 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - May 23, 2017) - CFN Media Group ("CFN Media"), the leading agency and digital media network dedicated to legal cannabis, today announced publication of an article covering ABcann Global Corp. (TSX VENTURE: ABCN) and why its pesticide-free approach sets a gold standard for the industry.




First Foods Group Retains Cannabis Business Expert Robert Hunt

Tue, 23 May 2017 08:59:27 EDT

Hunt will Explore Natural Synergies and Opportunities for First Foods in the Legal Cannabis Industry




Vaxil Launches Manufacturing of ImMucin Immunotherapy for Upcoming Clinical Trials

Tue, 23 May 2017 08:30:00 EDT

Selected to Present at 2017 Biomed Conference




Nutra Pharma Announces Collaboration with the International Security Group for Development of Nerve Agent Counter Measures

Tue, 23 May 2017 08:30:00 EDT

CORAL SPRINGS, FL--(Marketwired - May 23, 2017) - Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-AwayT in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced a collaboration today with International Security Group to develop its nerve agent counter measures.




CROS NT Announces Extended Partnership With Medidata -- Deploys RaveX

Tue, 23 May 2017 08:30:00 EDT

MAIDENHEAD, UNITED KINGDOM and CHAPEL HILL, NC--(Marketwired - May 23, 2017) - CROS NT today announced the go-live of its RaveX team in an extension of the company's partnership with Medidata.




OncBioMune CMO Begins Formulation Work on Tretinoin for Acute Promyelocytic Leukemia

Tue, 23 May 2017 08:30:00 EDT

BATON ROUGE, LA--(Marketwired - May 23, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a proprietary vaccine technology, is pleased to announce that its contract manufacturing organization (CMO) has begun formulation work on tretinoin, also known as all-trans retinoic acid (ATRA), at its state-of-the-art, cGMP-compliant facility in Colombia. Tretinoin is an oral drug for the treatment of Acute Promyelocytic Leukemia (APL). OncBioMune has acquired commercialization rights for tretinoin throughout Mexico, Central America and Latin America from the leading South American CMO.




FutureLand Corp (FUTL) CEO, Cameron Cox, Plans Site Visit in Grants Pass, Oregon to Discuss Upcoming Groovy Groves Cannabis Crop

Tue, 23 May 2017 08:27:19 EDT

DENVER, CO--(Marketwired - May 23, 2017) -  FutureLand Corp (OTCQB: FUTL), a dynamic growth company in the cannabis sector, announced today that its CEO, Cameron Cox, is planning a site visit to Groovy Groves LLC in Grants Pass, Oregon, from May 20 - May 25th.




Cannabis Wheaton Announces Private Placement of Special Warrants and Convertible Debenture Units

Tue, 23 May 2017 08:07:48 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 23, 2017) -




Golden Leaf to Hold Shareholder Call to Review First Quarter 2017 Results

Tue, 23 May 2017 08:00:00 EDT

TORONTO, ON--(Marketwired - May 23, 2017) - Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE: GLH) (CSE: GLH.CN) (CNSX: GLH) (OTCQB: GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced that it will hold a shareholder call to review first quarter 2017 results for the period ended March 31, 2017, at 9:00 am ET on May 26, 2017.




REPROCELL and Fox Chase Cancer Center Partner to Open Multi-Site Biosample Repository in India

Tue, 23 May 2017 07:59:17 EDT

Joint venture provides quality source of clinically annotated tissue specimens from vast Indian population




Does Weather Impact Performance or Reduce Capacity of Your Spray Dryers? New Food Industry Webinar Hosted by Xtalks

Tue, 23 May 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - May 23, 2017) - During a live broadcast on June 7, 2017, Bente Nielsen, Industry Manager of Global Food Industry at Munters A/S, will explain how food manufacturers can overcome climate related challenges by using air dehumidifiers in spray drying operations. The discussion will provide examples of how dehumidifiers have helped producers in the food industry experience the benefits of modern desiccant dehumidifiers, including producers of infant formula and different food ingredients.




Moleculin Biotech Issues Shareholder Update on FDA Designation of Orphan Drug and IND Status for Annamycin

Tue, 23 May 2017 07:30:00 EDT

HOUSTON, TX--(Marketwired - May 23, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center ("MD Anderson"), today announced that it has issued the following letter to its shareholders.




Biomerica to present at the 18th Annual B. Riley & Co. investor conference on May 24, 2017

Tue, 23 May 2017 07:29:00 EDT

IRVINE, CA--(Marketwired - May 23, 2017) - Biomerica Inc. (NASDAQ: BMRA) today announced it will present at the 18th Annual B. Riley institutional investor conference being held May 24-25, 2017 in Santa Monica, CA.




Self-Administration Injection Systems -- A Change in Market Trends Requires a Rethinking of Your Compounds Packaging, New Xtalks Webinar

Tue, 23 May 2017 07:00:00 EDT

Session will offer insight on the advantages of prefilled syringes and cartridges, including the various differentiators of the most commonly used syringe platforms -- pre-sterilized and bulk